Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hanmi Pharmaceutical
Biotech
Gilead pumps up virology pipeline with drug transporter deal
Gilead is paying Health Hope Pharma $10 million upfront for global rights to a candidate in virology.
Nick Paul Taylor
Sep 29, 2025 10:35am
Aptose to pay Hanmi up to $420M for myeloid inhibitor
Nov 4, 2021 10:37am
Hanmi's Type 2 diabetes drug curbs cardiovascular, kidney issues
Jun 28, 2021 5:19pm
Merck bags J&J castoff from Hanmi to expand NASH pipeline
Aug 4, 2020 6:51am
Sanofi culls pipeline dud, still looking to out-license meds
Apr 24, 2020 8:10am
Rapt edges into Asia with Hanmi I-O deal worth up to $118M
Dec 3, 2019 4:05pm
